Furthermore, a prognosis model assessing GBM and ROS levels found that high expression of ROS related genes, such as HSPB1, LSP1, and PTX3, correlates not only with the presence of M2 macrophages but also with shortened survival in GBM patients (61). The gene discussed is HSPB1; the disease is glioblastoma.